About 1 result found for searched term "Tisagenlecleucel" (0.129 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24822 | Tisagenlecleucel | Others |
| CTL019 | ||
| Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
